Anika Therapeutics, Inc. 4
4 · Anika Therapeutics, Inc. · Filed Jan 31, 2017
Insider Transaction Report
Form 4
Ahn Edward S.
Chief Tech. & Strategy Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-01-27+22,500→ 22,500 totalExercise: $50.13Exp: 2027-01-27→ Common Stock (22,500 underlying)
Footnotes (1)
- [F1]The stock options vest in three equal annual installments beginning January 27, 2018.